Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm, officially known as China National Pharmaceutical Group, is a massive state-owned enterprise in China and one of the largest healthcare companies globally. The company operates across the entire pharmaceutical value chain, including research and development, manufacturing, logistics, and retail distribution. Sinopharm gained significant international prominence for its development and global distribution of inactivated COVID-19 vaccines through its subsidiary, China National Biotec Group (CNBG). Beyond vaccines, the company provides a vast array of pharmaceutical products, medical devices, and healthcare services, serving as a critical pillar of China's national healthcare infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technology of the People's Republic of China.